Table 1 Patient characteristics (N = 40)

Patients entered and enrolled

40

Median age, years (range)

61.5 (30–76)

WHO performance status, n (%)

   0

18 (45.0)

   1

16 (40.0)

   2

6 (15.0)

Histology, n (%)

   Breast

1 (2.5)

   Ductal breast

31 (77.5)

   Lobular breast

8 (20.0)

Number of metastatic sites, n (%)

   1

12 (30.0)

   2

21 (52.5)

   3

4 (10.0)

   ≥4

3 (7.5)

Metastatic sites of disease^a, n (%)

   Visceral

35 (87.5)

   Liver

26 (65.0)

   Lung (including pleura)

17 (42.5)

   Nonvisceral only

5 (12.5)

Menopausal status, n (%)

   Pre-menopausal

20 (50.0)

   Menopausal

8 (20.0)

   Post-menopausal

10 (25.0)

   Unknown

2 (5.0)

Estrogen/progesterone receptors, n (%)

   Positive

23 (57.5)

   Negative

12 (30.0)

   Unknown

5 (12.5)